OMER Stock Analysis: Buy, Sell, or Hold?
OMER - Omeros Corporation
$10.16
-0.10 (-0.97%)
▼
5d:
-8.22%
30d:
-31.86%
90d:
-12.34%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 20, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When OMER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called OMER this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OMER shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OMER shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: OMER is currently trading at $10.16, which is considered oversold relative to its 30-day fair value range of $11.33 to $14.70. From a valuation perspective, the stock is trading at a discount (Forward PE: -338.7) compared to its historical average (78.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is currently testing key support at $9.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+293.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is currently testing key support at $9.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+293.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.33 -
$14.70
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding OMER? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 293.7% below Wall St target ($40.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -8.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$11.33 -
$14.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.86
Resistance Level
$12.55
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-338.67
Wall Street Target
$40.00
(+293.7%)
Revenue Growth (YoY)
14.9%
Profit Margin
871.0%
PE vs Historical
-338.7 vs 78.7
CHEAP
Share & Embed Analysis
Last updated: June 03, 2026 5:09 PM ET
Data refreshes hourly during market hours. Next update: 6:09 PM
Data refreshes hourly during market hours. Next update: 6:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David J Borges
SELL
30000 shares
2026-01-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 55 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 55 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$183 | 62 BUY |
Advanced OMER Option Strategies
Professional options setups generated by AI based on today's OMER price and gamma walls.
